Qure.ai

Qure.ai is a health tech company founded in 2016 with the mission of making healthcare more affordable and accessible through the power of Artificial Intelligence (AI). The company utilizes deep learning and AI to address the global healthcare challenge by offering solutions for the efficient identification and management of Tuberculosis (TB), Lung Cancer, and Stroke. These solutions not only support clinicians but also drive advancements in the pharmaceutical and medical device industries. Qure.ai's innovative approach empowers healthcare by enabling faster identification of conditions, facilitating treatment planning, and ultimately enhancing the quality of patient life. The company's last significant achievement includes securing a $65.00M Series D investment, marking a major milestone in its growth and development. This substantial investment was led by the Merck Global Health Innovation Fund on 25 June 2024. With its headquarter in the United States, Qure.ai stands at the forefront of AI-driven healthcare technology, poised to make a meaningful impact on the global healthcare landscape.